New Zealand markets open in 2 hours 43 minutes

SeaStar Medical Holding Corporation (ICU)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2132-0.1408 (-39.77%)
As of 03:16PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 26.70M
Enterprise value 25.74M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA -8.13

Trading information

Stock price history

Beta (5Y monthly) -1.01
52-week change 3-30.59%
S&P500 52-week change 324.69%
52-week high 31.7170
52-week low 30.1620
50-day moving average 30.5142
200-day moving average 30.5754

Share statistics

Avg vol (3-month) 32.29M
Avg vol (10-day) 31.31M
Shares outstanding 575.42M
Implied shares outstanding 675.42M
Float 872.33M
% held by insiders 111.81%
% held by institutions 15.06%
Shares short (15 May 2024) 41.94M
Short ratio (15 May 2024) 40.8
Short % of float (15 May 2024) 42.86%
Short % of shares outstanding (15 May 2024) 42.57%
Shares short (prior month 15 Apr 2024) 43.28M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-150.31%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-31.83M
Diluted EPS (ttm)-0.8600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.02M
Total cash per share (mrq)0.07
Total debt (mrq)4.06M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.68
Book value per share (mrq)-0.06

Cash flow statement

Operating cash flow (ttm)-11.48M
Levered free cash flow (ttm)-2.78M